Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients
Clinical trial NCT03318835 · UNKNOWN
Trial details
- NCT number
- NCT03318835
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-22
- Primary completion
- 2020-08-22
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.